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Using a forward genetics ENU mutagenesis
screen for recessivemutations that affect circa-
dian rhythmicity in the mouse, we isolated a
long period (26 hr) circadian mutant named
Overtime (Ovtm). Positional cloning and genetic
complementation reveal that Ovtm is encoded
by the F-box protein FBXL3, a component of
the SKP1-CUL1-F-box-protein (SCF) E3 ubiqui-
tin ligase complex. The Ovtm mutation causes
an isoleucine to threonine (I364T) substitution
leading to a loss of function in FBXL3, which in-
teracts specifically with the CRYPTOCHROME
(CRY) proteins. In Ovtmmice, expression of the
PERIOD proteins PER1 and PER2 is reduced;
however, the CRY proteins CRY1 and CRY2 are
unchanged. The loss of FBXL3 function leads to
a stabilization of the CRY proteins, which in turn
leads to a global transcriptional repression of
the Per and Cry genes. Thus, Fbxl3Ovtm defines
a molecular link between CRY turnover and
CLOCK/BMAL1-dependent circadian tran-
scription to modulate circadian period.
INTRODUCTION
The mechanism of circadian oscillators in mammals is
generated by a cell autonomous autoregulatory transcrip-
tion-translation feedback loop (Lowrey and Takahashi,
2004; Reppert and Weaver, 2002). In the primary negative
feedback loop, the bHLH-PAS transcription factors,
CLOCK (and its paralog NPAS2) and BMAL1 (ARNTL) di-
merize and activate transcription of the Period (Per1, Per2)
andCryptochrome (Cry1,Cry2) genes (Bunger et al., 2000;
Gekakis et al., 1998; King et al., 1997; Kume et al., 1999).
As the PER proteins accumulate, they form complexeswith the CRY proteins, translocate into the nucleus, and
interact with the CLOCK/BMAL1 complex to inhibit their
own transcription (Lee et al., 2001). This leads to a fall in
the inhibitory complex through turnover, and the cycle
starts again with a new round of CLOCK/BMAL1-acti-
vated transcription. Additional pathways in the circadian
gene network, such as the second negative feedback
loop (involving Rev-erba) in the positive limb of the oscilla-
tor, are thought to add robustness to the circadian mech-
anism (Preitner et al., 2002; Sato et al., 2004). Finally, post-
translational modifications play critical roles in regulating
the turnover, cellular localization, and activity of circadian
clock proteins (Eide et al., 2005; Gallego and Virshup,
2007; Lowrey et al., 2000).
Despite this progress, it is clear that a significant num-
ber of genes that strongly influence and regulate circadian
rhythms in mammals remain to be discovered and identi-
fied (Shimomura et al., 2001; Takahashi, 2004). Forward
genetic screens have been one of the most effective tools
for circadian gene discovery (Takahashi, 2004; Takahashi
et al., 1994; Vitaterna et al., 1994), and we have used this
approach to screen the mouse genome for circadian
rhythm mutants generated in the Neurogenomics Project
in the Center for Functional Genomics at Northwestern
University (Vitaterna et al., 2006).
Using a forward genetic approach in mice, we report
here the isolation and positional cloning of a novel circa-
dian period mutant in mice. This mutation reveals a defect
in an orphan member of the F-box protein family, FBXL3,
which leads to a stabilization of CRY protein levels and
a global repression of Per and Cry gene transcription.
RESULTS
Mutagenesis, Screening, and Identification
of the Overtime Gene
In an N-ethyl-N-nitrosourea (ENU) recessive screen using
the BTBR T+ tf/J (BTBR/J) inbred mouse strain (Siepka
and Takahashi, 2005a), we identified a long period mutantCell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc. 1011
Figure 1. ENU Mutagenesis Screen
(A) Mutant mouse production. See Experimental Procedures for description.
(B) Histogram showing circadian period values of 3198 mice in this screen. Gray shading indicates ±3 standard deviations (SD) from the mean. The
original Overtime mutant is indicated by the arrow.
(C) Representative actogram of a wild-type BTBR/J mouse. The actogram is double plotted where 48 hr of activity is represented on each horizontal
line. The mice were kept on a LD12:12 cycle (represented in the bar above) for the first 7 days and then released into constant darkness (DD) for
21 days (indicated by the arrowhead on the right).
(D) Actogram of the original Ovtm G3 mouse in the screen. This animal (an Ovtm homozygote) had a free running period of 25.83 hr.
(E) Actogram of an Ovtm G3 littermate. This animal (a heterozygote carrier and founder of the Ovtm strain) had a free running period of 23.98 hr.with a 25.8 hr period length, which is more than 10 stan-
dard deviations from the mean in this screen (Figure 1).
This mutant, named Overtime, is semidominant and auto-
somal. In crosses with C57BL/6J and C3H/HeJ mouse
strains, the homozygous mutant phenotype is distinct
with an average circadian period of 26.2 hr and a range
of about 25–28 hr, which is indistinguishable from the orig-
inal mutant (Figures 2A–2D).Ovtmmaps to a 1.7 cM inter-
val on chromosome 14 between D14Mit265 (5 recombi-
nants/642 meioses) and D14Mit197 (6 recombinants/642
meioses) (Figure 2E). This region corresponds to a 4 Mb
interval and contains 18 open reading frames (Assembly
build NBI m36 December 2005, Gene build June 2006),
none of which corresponds to previously known circadian
clock genes (Figure 3A) (Lowrey and Takahashi, 2004).
Several genes in the nonrecombinant interval were likely
candidates for Ovtm. Protein degradation machinery has
as an important role in the clock mechanism (Gallego
and Virshup, 2007), and there are several ubiquitin-path-1012 Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc.way related genes in this interval (Uch13, Lmo7, Fbxl3,
Phr1, 2610206B13Rik, and Ndfip2). Because the entire
4 Mb Ovtm interval has a low polymorphism rate and
shares the identical haplotype with the mapping strains,
the resolution of meiotic mapping could not be increased.
This region of the genome is part of the piebald deletion
complex, which contains several developmentally impor-
tant genes (Peterson et al., 2002). This may have caused
selection of a limited number of ancestral haplotypes in
this region of chromosome 14, which would in turn lead
to a low polymorphism rate.
We sequenced all annotated exons for the 18 candidate
genes in the Ovtm interval and found only a single nonsy-
nonymous point mutation within the coding region of
Fbxl3. There is a single base transition from A to G in
exon 5 of Fbxl3 in Ovtm mice as compared to wild-type
BTBR/J mice. This mutation cosegregated perfectly with
the long-period phenotype of Ovtm/Ovtm mice (0 recom-
binations out of 642 meioses; Figures 2D and 2E).
Figure 2. Semidominant Phenotype of Overtime and Genetic Mapping
(A) Representative actograms of wild-type, (B)Ovtm/+, and (C)Ovtm/Ovtm (BTBR/J3C57BL/6J) F2mice. The actograms are plotted as described in
Figure 1.
(D) Period distribution of F2 intercross progeny. The three panels from top to bottom represent wild-type,Ovtm/+, andOvtm/Ovtmmice, respectively.
Analysis of variance (ANOVA) of the periods was performed on the three populations of F2 mapping mice (as defined by Ovtm genotype). Significant
effects of the Ovtm allele were detected (DF = 2; F = 2112; p < 1 3 1027).
(E)Ovtmmaps betweenD14Mit265 andD14Mit197. The chromosome 14 schematic lists the distal markers used tomapOvtm. Haplotypes of the 321
Ovtm/Ovtm F2 intercross progeny (642 meioses) are on the right. Black boxes represent BTBR/J alleles, while gray boxes represent heterozygous
alleles (BTBR/J and C57BL/6J). The number of recombinants per total meioses is indicated to the right of the haplotype map.The point mutation converts amino acid residue 364 from
isoleucine to threonine in FBXL3 (Figures 3A and 3B). This
isoleucine residue is highly conserved in FBXL3 from ver-
tebrates and in the mouse paralog FBXL21 (Figure 3B).
FBXL3 is a member of the F-box protein family with leu-
cine rich repeats (LRR), which is defined by its founding
member, SKP2 (S-phase kinase-associated protein-2)(FBXL1) (Jin et al., 2004). SKP2 is the F-box protein moiety
in the SKP1-CUL1-F-box-protein (SCF)SKP2 E3 ubiquitin
ligase complex, which mediates the recognition and ubiq-
uitination of the CDK2 inhibitor, p27Kip1, to target it for
proteasomal degradation (Cardozo and Pagano, 2004).
Structural studies show that CUL1 provides a rigid scaf-
fold, upon which SKP1 and RBX1 subunits assemble:Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc. 1013
Figure 3. Positional Cloning of Overtime and Identification of Fbxl3 Mutation
(A) Physical map of the Ovtm interval. Ovtm maps to a 4 Mb region of chromosome 14. Red blocks represent the 18 candidate genes within the
interval. The asterisks indicate the location of the Ovtm mutation.
(B) FBXL3 is an F-box protein. FBXL3 contains one F-box domain (red box) and 11 leucine rich regions (LRR) (yellow hexagons) (Jin et al., 2004).
b strand (blue arrow) and a-helical (red ovals) regions (based on analysis using PROF in the PredictProtein server [Rost et al., 2004]) of LRR10
and LRR11 are indicated above the sequence. In the protein alignment, yellow indicates amino acid identity, green indicates conservative substitu-
tions, white indicates nonconservative substitutions, and red indicates the I364T Ovtm mutation.1014 Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc.
SKP1 interacts with SKP2 via its N-terminal F-box motif
(Zheng et al., 2002). Recent work shows that the LRR re-
gion and the C-terminal tail of SKP2 interact with the sub-
strate, p27Kip1, and the accessory protein, CKS1 (Hao
et al., 2005). FBXL3, which has 11 LRRs, can be aligned
with SKP2, which has 10 LLRs based on its protein struc-
ture; however, the C termini of SKP2 and FBXL3 are not
conserved, likely due to the recognition of different sub-
strates (Hao et al., 2005). TheOvtm I364T mutation occurs
in the C terminus of FBXL3 between LRR10 and LRR11,
where the alignment with SKP2 becomes divergent (Fig-
ure 3B). Because the LRR domains of F-box proteins are
involved with substrate recognition with the SCF complex,
we hypothesized that the I364T mutation could alter the
interaction of FBXL3 with its substrates.
Because we isolated only onemutant allele of Fbxl3 and
either a second independent allele, rescue, or functional
evidence is required for proof in positional cloning (Taka-
hashi et al., 1994), we used genetic complementation tests
to confirm that Ovtm was allelic with Fbxl3. A search of
the International Gene Trap Consortium (IGTC) database
(http://www.genetrap.org/) revealed three gene traps in
Fbxl3, and we obtained one gene trap ES cell line (S13-
12G1) from Philippe Soriano (Chen et al., 2004). ES cells
were microinjected into blastocysts to produce chimeras,
and 19 out of 19 mice were chimeric. Because the ES cell
contribution in thesechimeraswas>95%, theyweremated
directly to Ovtm/Ovtm mice to test for germline transmis-
sion and genetic complementation simultaneously. The
crosses show that Ovtm and the Fbxl3 gene trap (GT) fail
to complement each other, thus providing independent
and definitive evidence that Ovtm is an allele of Fbxl3
(Figure 3C). Interestingly, the period length of GT/Ovtm
mice is indistinguishable from Ovtm homozygotes, sug-
gesting that theOvtmmutant allele is likely a hypomorphic
or loss-of-function allele.
The mRNA expression of Fbxl3 itself in the mouse is
ubiquitous, but enriched in the brain (data not shown).
Northern blot analysis of Fbxl3 from liver in wild-type
(WT) and Ovtm mice did not reveal any significant differ-
ences in transcript size or abundance between the geno-
types. In addition, there was no obvious circadian rhythm
in Fbxl3mRNA expression in the liver. In situ hybridization
of Fbxl3 shows clear RNA expression in the suprachias-
matic nucleus (SCN) and throughout the brain (see Sup-
plemental Data).
Effects of the OvertimeMutation on Circadian Clock
Gene Expression
Because FBXL3 is likely a component of an SCF E3 ubiq-
uitin ligase complex, we examined the in vivo expression
patterns of circadian clock proteins in mouse tissues toexplore whether Ovtm might alter their abundance by af-
fecting degradation. WT and Ovtm mice were housed in
runningwheel cages tomeasure activity rhythms andwere
transferred to constant darkness (DD) for 10–14 days. An-
imals were killed under infrared illumination every 3 hr in
DD based on circadian time (CT) to compensate for the
differences in circadian period between WT and Ovtm
mice. Figure 4A shows the expressionpatterns of the clock
proteins, CRY1, CRY2, PER1, PER2, CLOCK, and BMAL1
in liver and cerebellum. InWTmice, there were low ampli-
tude rhythms of CRY1 and CRY2 and high amplitude
rhythms of PER1 and PER2 as reported previously (Lee
et al., 2001). In Ovtm liver tissue, CRY1 and CRY2 protein
patterns were not significantly altered; however, PER1
and PER2 levels were significantly reduced (Figure 4B).
In the cerebellum, the effects of Ovtm were more striking.
Although CRY1 levels were not different, CRY2 levels
were significantly elevated in Ovtm mice consistent with
the hypothesis that CRY degradation is impaired. In addi-
tion, there were very clear reductions in the levels of PER1
and PER2. The levels of CLOCK and BMAL1 were not de-
tectably changed in either tissue inOvtmmice (Figure 4A).
The reduction of PER1 and PER2 levels in Ovtm mice is
significant in both liver and cerebellum, and this finding
is unexpected and counterintuitive. We would have ex-
pected to see an increase rather than a decrease in protein
abundance if the PER proteins were targets of FBXL3 be-
cause the Ovtm mutation is a loss-of-function mutation.
This suggests that it is unlikely that the PER proteins are
targets of FBXL3 and that the reduction in PER levels
could occur as a consequence of the negative feedback
on CLOCK/BMAL1-dependent transcription.
To explore the reasons for the reduction in PER1 and
PER2 protein abundance, we profiled the in vivo circadian
mRNA expression patterns forCry1,Cry2, Per1, Per2, and
Dbp in the liver and cerebellum of mice maintained in DD.
As shown in Figure 4C, the Ovtm mutation caused signif-
icant reductions in the mRNA abundance of all of these
cycling transcripts with the strongest effects being seen
with Cry1 and Per2 in the cerebellum. At the mRNA level,
both a delay in the peak time and a reduction in abun-
dance can be seen. Importantly, although CRY1 and
CRY2 protein levels were not lower inOvtmmice, the cor-
responding mRNA levels for Cry1 and Cry2 are signifi-
cantly reduced in both tissues. Similar reductions in the
mRNA levels for Cry1 and Per2 in Ovtm mice could also
be observed in the SCN using in situ hybridization (see
Supplemental Data). In addition, mRNA levels for the cy-
cling CLOCK target gene, Dbp (Ripperger and Schibler,
2006), were very strongly reduced in Ovtm mice. Thus,
the mRNA profiling experiments point to an interesting
and unexpected consequence of the Ovtm mutation: a(C) Complementation test for Ovtm and Fbxl3. The left panel outlines the mating scheme for the complementation assay. Ovtm mice were crossed
to heterozygous Fbxl3 gene trap (GT) mice. Circadian behavior was recorded for 39 progeny. The actograms are representative of Ovtm/+ (top) and
GT/Ovtm (bottom) mice. In the period histogram distribution black bars representOvtm/+mice (mean = 24.20 hr; SD = 0.26; N = 21), while white bars
represent GT/Ovtm mice (mean = 26.62 hr; SD = 0.41; N = 18). Student’s t test, unequal variances, shows a significant difference between the two
populations (DF = 28; T = 21.47; p = 6.3 3 1019).Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc. 1015
Figure 4. Altered Circadian Clock Gene Expression in Overtime Mice
(A) Protein oscillation profiles of clock genes from liver and cerebellum. Wild-type andOvtmmutant tissue was collected at indicated circadian times.
Western blotting was performed on total protein extracts with indicated antibodies. Each blot shows a representative example from three indepen-
dent replicates.
(B) Quantification of proteins from liver and cerebellum. Data are taken from three independent experiments. Protein levels were quantified using
Scion Image (http://www.scioncorp.com). Filled circles with solid line represent normalized values from wild-type, and open circles with dotted
line represent normalized values from Ovtmmice. Error bars represent SEM for each time point from three independent replicates. Two-way ANOVA
shows significant statistical differences betweenWT and Ovtm mutant for both PER1 and PER2 expression in cerebellum (p < 0.001 and p < 105,
respectively) and in liver (p < 105 and p < 0.001, respectively). In contrast to PER, only CRY2 shows a significant difference in expression from
cerebellum (p < 105) between wild-type and Ovtm mice.1016 Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc.
reduction in steady-state mRNA expression of Cry1,Cry2,
Per1, Per2, and Dbp, which are all transcriptional targets
of the CLOCK/BMAL1 complex (Gekakis et al., 1998;
Kume et al., 1999; Ripperger and Schibler, 2006; Yoo
et al., 2005).
Comparison of the effects of Ovtm on protein versus
mRNA abundance suggests that there are two different
effects on the expression of the CRY and PER proteins.
The PER protein levels appear to be reduced as a conse-
quence of reduced transcript levels. By contrast, the CRY
protein levels are not reduced, even in the face of reduced
transcript levels. This suggests that potential reductions in
CRY protein levels caused by reduced Cry transcript
levels could be compensated by a reduction in protein
degradation.
Interaction of OVTM with Circadian Clock Proteins
The Pagano laboratory has found that FBXL3 targets CRY
proteins for ubiquitination and degradation (personal
communication). To confirm these results and determine
whether the Ovtmmutation affects interactions with CRY,
we examined the interaction of FBXL3 orOVTMwith circa-
dian clock proteins by immunoprecipitation assays. First,
we used tagged Fbxl3, Ovtm, and bTrCP1 expression con-
structs to transfect NIH 3T3 cells, which contain circadian
oscillators and express clock proteins (Nagoshi et al.,
2004). Cell lysates were immunoprecipitated with anti-
FLAG or anti-V5 antibodies, and interactions with CRY1,
CRY2, PER1, and PER2 native proteins were probed on
western blots (Figure 5A). Both FBXL3 and OVTM inter-
acted strongly with native CRY1 and CRY2 proteins. Very
weak or no interaction of FBXL3 was seen with PER1 and
PER2, especially in comparison to that seen between the
PERs and bTrCP1, an F-box protein known to interact
with the PERs (Eide et al., 2005; Shirogane et al., 2005)
(Figure 5A). In all experiments, there was a discernibly
stronger interaction of the CRY proteins with FBXL3 rela-
tive to OVTM, but the difference was subtle.
We also used tagged proteins in coimmunoprecipitation
assays in 293A cells, which are easily transfected and ex-
press relatively low levels of clock proteins. Both FBXL3
and OVTM interacted strongly with CRY1 and CRY2 (Fig-
ure 5B). To explore the weak interaction of FBXL3 with
PER proteins, tagged Per constructs were also tested.
All three PER proteins showed interactions with FBXL3
and OVTM; however, the strongest interactions were seen
with PER2. Because PER2 interacts very strongly with
CRY1 (Griffin et al., 1999; Kume et al., 1999; Lee et al.,
2001), it is likely that the interactions seen here with
FBXL3 may be indirect via CRY1.
Effects of OVTM on CRY Degradation
To determinewhether OVTM is less efficient than FBXL3 in
inducing the degradation of CRY1, we compared the ef-fects of FBXL3 and OVTM on the stability of CRY1 follow-
ing cycloheximide treatment to prevent de novo protein
synthesis in transfected cells (Figure 5C). In 293A cells,
transfected CRY1 is relatively stable with a half-life of
6.4 hr (Figure 5D). Addition of FBXL3 or OVTM increased
the turnover of CRY1 significantly with FBXL3 leading to
a 1.7 hr CRY1 half-life and OVTM leading to a 2.5 hr CRY1
half-life (Figure 5D). Thus, FBXL3 expression leads to the
degradation of CRY1, and this degradation is blocked by
the 26S proteasomal inhibitor MG132 (Figure 5C). OVTM
is less effective than FBXL3 in causing CRY1 degradation
under these conditions, and the half-life parameter, K, is
significantly different (p = 0.016) between FBXL3 and
OVTM in the model-based nonlinear exponential decay
analysis with GraphPad Prism 4. Interestingly, the turn-
over of FBXL3 is also affected by the OVTMmutation (Fig-
ure 5C; bottom). FBXL3 is relatively stable with a half-life of
greater than 7 hr; whereas, OVTMhas amuch shorter half-
life of 2.7 hr (Figure 5D). Therefore, there are two effects of
the OVTM mutation: (1) a reduction in proteasome-medi-
ated CRY1 degradation and (2) a decreased stability of
the OVTM protein itself, both of which could contribute
to a loss-of-function phenotype.
To determine whether these changes in CRY1 stability
seen in transfected cells are physiological, we used fibro-
blasts prepared from either WT or Ovtm mice and deter-
mined the half-lives of native CRY1 and PER2 proteins
in these cells. Fibroblast cultures were synchronized with
10 mM forskolin and treated with cycloheximide. The half-
lives of CRY1 and PER2 were then determined by western
blot against native proteins. As shown in Figures 5E and
5F, the half-life of CRY1 in Ovtm fibroblasts is extremely
long (>9 hr), as compared to WT cells (half-life = 5.2 hr).
The overall levels of PER2 in Ovtm fibroblasts were very
low, similar to that seen in the cerebellum. When the half-
life of PER2 was determined, however, there was no de-
tectable difference in the half-life of PER2 in WT and
Ovtm cells (Figure 5F). Thus, these experiments in fibro-
blasts from WT and Ovtm mice show that native CRY1,
but not PER2, turnover is specifically altered by the Ovtm
mutation. These experiments strongly suggest that OVTM
is selectively defective in its ability to target CRY1 for deg-
radation by the proteasome.
Effects of Ovtm on Per and Cry Transcription
To understand why the steady-state transcript levels of
Per andCry are reduced inOvtmmice, we estimated tran-
scription rates by measurement of pre-mRNA levels and
mRNA stability by half-life experiments. In both liver and
cerebellum, Cry1 and Per2 pre-mRNA levels are strongly
correlated with steady-state mRNA abundance levels with
lower pre-mRNA levels observed in Ovtm tissue (Fig-
ure 6A). As seen for steady-state mRNA levels, the reduc-
tion in Cry1 and Per2 pre-mRNA levels was most clear in(C) Real-time RT-PCR analysis for clock gene expression in wild-type and Ovtm mice. Filled circles with solid line represent wild-type, and open
circles with dotted line represent values from Ovtm mice. All cycling genes show a significant reduction of mRNA level from Ovtm mice compared
to WT mice in liver and cerebellum except for Per2 in liver (N.S.). Error bars represent SEM for each time point from four independent replicates.Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc. 1017
Figure 5. Interaction of FBXL3 and OVTM with Circadian Clock Proteins
(A) NIH 3T3 cells were transfected with FLAG-Fbxl3, FLAG-Ovtm, and V5-bTrcp1. Twenty-four hours after transfection, cells were incubated with
20 mM MG132 for 8 hr before collection. Immunoprecipitation was performed with anti-Flag or anti-V5 antibody. Immunoprecipitated proteins
were further analyzed by western blotting with anti-PER and anti-CRY antibody.
(B) Confirmation of interaction between FBXL3with CRY andPER2. In the top panel, 293A cells were transfected with Cry-HA and FLAG-Fbxl3, FLAG-
Ovtm. F+O is cotransfection of FLAG-Fbxl3, FLAG-Ovtm. Thirty-six hours after transfection, cells were harvested, and reciprocal immunoprecipita-
tions were performed with indicated antibodies. Open arrowheads indicate CRY, filled arrowheads indicate FBXL3 or OVTM. Lower panel, Per-V5
were cotransfected with FLAG-Fbxl3, FLAG-Ovtm. Open arrowheads indicate immunoprecipitated FBXL3 or OVTM, filled arrowheads indicate
FBXL3 or OVTM from input.
(C) Effects of Fbxl3 and Ovtm on CRY1 and FBXL3 protein stability. Cry1-HA was cotransfected with FLAG-Fbxl3 or FLAG-Ovtm with HA-Ubiquitin
(Ub). Twenty-four hours after transfection, 20 mg/ml cycloheximide (CHX) was added and incubated for the indicated time. Abundance of CRY1,
FBXL3, and OVTM was measured by western blotting. Upper panel: Inhibition of CRY degradation by MG132 treatment plus CHX treatment. Lower
panel:Ovtmmutation cause accelerated degradation of FBXL3 through the proteasomal degradation pathway. b-actin was used as a loading control.
(D) Quantitation of the effects of Fbxl3 andOvtm on CRY1 and FBXL3 protein stability. Data are taken from the three independent experiments. In the
upper panel, effects of FBXL3 on CRY1 stability in 293A cells is shown. Open squares: Cry1 only; filled circles: Cry1 cotransfected with Fbxl3; open
circles: Cry1 cotransfected with Ovtm mutant. The half-life of CRY1 is reduced by either FBXL3 (half-life: 1.7 hr) or OVTM (half-life: 2.5 hr). OVTM
coexpression was less effective in CRY1 degradation compared to FBXL3 (the half-life parameter, K, is significantly different, p = 0.16, using
model-based nonlinear exponential decay analysis with GraphPad Prism 4). In the lower panel, effect of the Ovtm mutation on the half-life of
FBXL3 is shown. Closed circles and open circles represent FBXL3 and OVTM, respectively. In the presence of CRY1, the Ovtm mutation
caused a reduction in the protein stability of OVTM (the half-life parameter, K, is significantly different; p = 0.0003). Error bars represent SEM for
each time point from three independent replicates.1018 Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc.
the cerebellum. Thus, Ovtm strongly reduces the tran-
scription of Cry1 and Per2 in vivo, consistent with the hy-
pothesis that transcription rates account for the reduction
in steady-state mRNA abundance. To reinforce this hy-
pothesis, we also measured the half-lives of mRNAs for
Cry1, Cry2, Per1, and Per2. WT and Ovtm fibroblasts
were treated with Actinomycin D to inhibit de novo tran-
scription, andmRNA half-life was determined by quantita-
tive PCR. As shown in Figure 6B, although there are differ-
ences in the initial mRNA levels ofCry1 andPer2 as seen in
the cerebellum, the half-lives of all four transcripts are not
significantly different in WT and Ovtm cells using model-
based nonlinear exponential decay analysis with Graph-
Pad Prism 4. Thus, taken together, these experiments
argue that the reduced mRNA levels of the Cry and Per
genes in Ovtm mouse tissues are due to a reduction in
transcription of these genes.
To address the functional consequences of the muta-
tion, we assessed whether Fbxl3 or Ovtm could affect
Clock/Bmal1-mediated transcriptional activation. We
asked whether Fbxl3 or Ovtm could modulate the inhibi-
tory effects of Cry1 on Clock/Bmal1-induced transcription
using a Per2 E2 enhancer driving luciferase (Yoo et al.,
2005). In Figure 6C,Clock/Bmal1 transfection activates lu-
ciferase activity6-fold. As recently reported (Kwon et al.,
2006), treatment with the proteasomal inhibitor MG132
significantly reduces the magnitude of Clock/Bmal1 acti-
vation. As expected, Cry1 cotransfection strongly in-
hibited Clock/Bmal1 activation (Griffin et al., 1999; Kume
et al., 1999). The addition of Fbxl3 strongly diminished
the Cry1-dependent inhibitory effects on Clock/Bmal1 ac-
tivation, while addition of Ovtm was much less effective
than that seen with Fbxl3. Western blots confirmed that
the expression levels of FBXL3 and OVTMwere compara-
ble. However, Fbxl3 and Ovtm transfection reduced the
levels of CRY1, consistent with the CRY1 degradation ex-
periments in Figure 5C. Thus, FBXL3 and OVTM both
reduced CRY1 expression levels, and the reduction in
CRY1 is correlated with a reduction in CRY1-dependent
inhibition of CLOCK/BMAL1 activation (linear regression
analysis of CRY1 level versus PER::LUC activity: slope is
significant; p = 0.0181; Pearson’s correlation coefficient
R = 0.67). Thus, one possible explanation for the differ-
ence in CLOCK/BMAL1-dependent transcription in WT
and Ovtm tissues could be that FBXL3 normally provides
a steady-state turnover of CRY via proteasomal degrada-
tion that is reduced by theOvtmmutation. This could then
lead to an accumulation of CRY to suppress CLOCK/
BMAL1-dependent transcription.DISCUSSION
We have shown that the ENU-induced Overtimemutant is
caused by an I364T mutation in the mouse FBXL3 protein,
a member of the F-box protein with leucine rich repeats
family (Jin et al., 2004). The OVTM protein is less efficient
than FBXL3 in degrading CRY1, thus providing genetic ev-
idence that FBXL3 appears likely to be a primary F-box
protein within an SCF E3 ubiquitin ligase complex (Car-
dozo and Pagano, 2004) that targets the CRY proteins
for degradation in the proteasome. The I364T OVTM
mutation lengthens circadian periodicity 2.5 hr in mice.
We propose that the phenotypic effects of theOvtmmuta-
tion occur primarily through two mechanisms: (1) loss of
FBXL3 function leading to stability of CRY1 protein and
(2) repression of CLOCK/BMAL1-dependent transcrip-
tional activation. These two processes lead to a striking
reduction in the expression of the PER proteins, which is
caused by a reduction in transcription of the Per genes.
By contrast, the levels of CRY are not reduced by the
Ovtmmutation despite lower rates of Cry transcription. In-
deed in the cerebellum, the level of CRY2 protein is signif-
icantly higher as expected (perhaps due to the slightly
higher relative rate of transcription of Cry2 compared to
Cry1 in the cerebellum inOvtm versusWTmice). However,
the levels of CRY1 protein were not elevated inOvtmmice.
Because the majority of CRY protein is cytoplasmic (Lee
et al., 2001), we also examined levels of CRY1 in the nu-
cleus but did not detect an increase in CRY levels in nu-
clear fractions from the liver of Ovtm mice in comparison
to WT (data not shown). In retrospect, because the tran-
scription of the Cry1 gene is strongly attenuated by the
Ovtm mutation, it is surprising that CRY1 protein levels
are not lower. The low rate of CRY1 protein degradation
in Ovtm tissues must offset the lower synthesis of CRY1
so that the steady-state abundance of CRY1 protein is
similar in Ovtm and WT mice. Importantly however, be-
cause the turnover rate of CRY1 is reduced, the clearance
of CRY1 will be prolonged even if the initial steady-state
abundance levels are comparable. This would then lead
to a prolongation of the CRY-dependent repression phase
of the circadian cycle. If such a prolongation extended
CRY repression for 2–3 hr, the period-lengthening pheno-
type seen inOvtmmice would follow as a consequence. It
will be of great interest to test existing biochemical models
of the circadian oscillator (Forger and Peskin, 2003;
Leloup and Goldbeter, 2004) for these phenotypic effects.
In particular, it will be important to determine whether
global changes in the set point for transcription rates of(E) Stability of endogenous CRY1 and PER2 in Ovtm ear fibroblast cells.WT and Ovtm fibroblast cells were plated 48 hr before the experiment and
synchronized by 1 hr treatment with 10 mM forskolin. A total of 20 mg/ml CHXwas administered during indicated time. Protein extracts from harvested
cells were analyzed with western blotting using anti-CRY1 and anti-PER2 antibody. a-tubulin was used as a loading control.
(F) Half-life measurements of endogenous CRY1 and PER2 proteins inWT and Ovtm fibroblasts. Data are taken from the three independent exper-
iments. Shown in the upper panel is the time course of CRY1 levels following addition of CHX. Closed circle are fromWT fibroblasts and open circles
are fromOvtm cells. CRY1 degradation is muchmore rapid inWT fibroblasts (half-life: 5.2 hr) than inOvtm fibroblasts (>>9 hr) (the half-life parameter,
K, is significantly different, p < 0.0001). Shown in the lower panel are half-life measurements of PER2 proteins in WT and Ovtm fibroblasts. Closed
circles are from WT fibroblasts and open circles are from Ovtm fibroblasts. Error bars represent SEM for each time point from three independent
replicates.Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc. 1019
Figure 6. Effects of Ovtm on Cry and Per Transcription, mRNA Stability, and CLOCK/BMAL1-Mediated Transcriptional Activation
(A) Real-time RT-PCR analysis of Per2 andCry1 pre-mRNA in cerebellum and liver fromWT andOvtmmice. Error bars represent ± SEM for each time
point.
(B) mRNA half-life measurements of Cry1, Cry2, Per1, and Per2. WT and Ovtm fibroblast cells were plated 48 hr before, then treated with 5 mg/ml
Actinomycin D for indicated amount of time. Total RNA was isolated from the harvested cells, and quantitative PCR was performed as described
previously. There were no significant differences in mRNA half-lives between WT and Ovtm cells.
(C) Effects of FBXL3 on CLOCK/BMAL1-mediated transcriptional activation. pGL3Basic-E2 was transfected into 293A cells with the indicated DNA
constructs (plus sign). Each value represents the mean ± SEM of three replicates from a single experiment. The results shown are representative of
at least three independent experiments. The lower panel shows western blots from the same extracts used in the luciferase assays. Anti-HA and
anti-FLAG antibodies were used to detect CRY1-HA and FBXL3, OVTM-FLAG, respectively.the clock genes occur as a result of decreases in the deg-
radation of the CRY proteins and whether the changes in
CRY turnover rates can account for the period-lengthen-
ing phenotype ofOvtmmice. In addition, it will be interest-
ing to explore the reasons underlying the tissue-specific
differences observed in Ovtm mice.
These results highlight the significance of an SCFFBXL3
E3 ubiquitin ligase complex in regulating the stability and
kinetics of CRY degradation. The specificity of the
FBXL3 interaction with the CRY proteins is striking and1020 Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc.suggests that additional F-box proteins may regulate
other circadian clock components. The first example of
an F-box protein playing a role in circadian rhythmicity
was the Arabidopsis gene ZEITLUPE (ZTL), which en-
codes an F-box protein with an N-terminal LOV domain
and C-terminal kelch repeats (Somers et al., 2000). ZTL
targets the Arabidopsis clock protein, TOC1, for degrada-
tion by the proteasome and is thought to regulate circa-
dian period by controlling TOC1 stability (Mas et al., 2003).
In addition, the F-box protein, FKF1, mediates the cyclic
degradation of CDF1, a repressor of the photoperiodic
gene CONSTANS (Imaizumi et al., 2005), and the F-box
protein, AFR, is a positive regulator of phytochrome
A-mediated light signaling in Arabidopsis (Harmon and
Kay, 2003). FBXL3 is the second example of a mammalian
F-box protein regulating the circadian clock proteins. The
first example is bTrCP, which has been shown to interact
directly with the PER proteins (Eide et al., 2005; Shirogane
et al., 2005). Evidence for bTrCP in the circadian pathway
first emerged from Drosophila in which it was shown that
Slimb, the ortholog of bTrCP, regulated circadian expres-
sion of PER and TIM (Grima et al., 2002; Ko et al., 2002).
Interestingly, inNeurospora, the ortholog of bTrCP, FWD1,
regulates the degradation of the clock protein, FRE-
QUENCY (He et al., 2003). More recently, JETLAG, the
Drosophila ortholog of Fbxl15, has been shown to play
a critical role in light-induced TIM degradation by the pro-
teasome (Koh et al., 2006). InDrosophila two different SCF
complexes appear to control TIM levels: (1) a circadian
pathway involving Slimb and (2) a light-dependent path-
way involving JET (Koh et al., 2006). It will be interesting
see whether similar types of mechanisms are conserved
in mammals. Because of the differences in the roles of
the PER and CRY proteins in Drosophila and in mammals
(Allada et al., 2001; Young and Kay, 2001), where CRY is
primarily a circadian repressor (not a photoreceptor),
FBXL3 appears to function in a circadian SCF complex-
mediated pathway. Unlike Drosophila PER, the PER1
and PER2 proteins in mammals are transcriptionally in-
duced by light in the SCN. It will be interesting to see
whether bTrCP functions in a circadian or in a light-depen-
dent SCF pathway for PER degradation (analogous to the
TIM protein in Drosophila).
Using a forward genetics approach in mice, we have
identified FBXL3 as a new molecular component of the
negative feedback loop that generates circadian rhythmic-
ity. Our results both confirm biochemical studies from the
laboratory of Pagano (personal communication) showing
that the SCFFBXL3 E3 ubiquitin ligase complex targets
CRY1 for ubiquitination and provide in vivo evidence that
links CRY stability to CLOCK/BMAL1-mediated transcrip-
tional activation. InOvtmmice thefineequilibriumbetween
activation and repression of clock gene transcription is
disturbed due to the mutation. Future studies will further
clarify how this equilibriumbetween activators and repres-
sors leads to the generation of circadian periodicity.
EXPERIMENTAL PROCEDURES
Mouse Strains
BTBR T + tf/J (Stock #002282), C57BL/6J (Stock # 000664), C3H/HeJ
(Stock # 000659), and 129S1/SvImJ (Stock #002448) mice were pur-
chased from The Jackson Laboratory (Bar Harbor, ME). CD-1 (Strain
code 022) female mice were purchased from Charles River Laborato-
ries (Wilmington, MA). All mice were housed under LD12:12 unless
otherwise noted. All animal care and experimental treatments were
in accordance with Northwestern University guidelines for animal
care and use.Mutagenesis and Breeding Scheme
N-Ethyl-N-nitrosourea (ENU) (Sigma cat #N3385) was prepared as de-
scribed previously (Siepka and Takahashi, 2005a). Six-week-old male
BTBR/J mice were injected with 250 mg/kg body weight of ENU. After
a 6-week recovery period, the ENU-treated mice were mated with
wild-type BTBR/J females to generate generation 1 (G1) males. G1
males were mated with wild-type BTBR/J females to produce G2 fe-
males. Four G2 females were backcrossed to their G1 fathers to pro-
duce G3mice for phenotyping. Five G3 mice from every G2 backcross
(20 mice per G1 pedigree) were phenotyped to ensure an 85% proba-
bility of detecting a recessive mutation. 3198 G3 mice from 216 G1
pedigrees were successfully screened from a total of 3609 G3 mice
produced.
Measurement of Free-Running Period
Mice (6–10 weeks of age) were placed in individual running wheel ca-
ges, and activity was recorded using the ClockLab data collection sys-
tem (Actimetrics, Wilmette, IL). After 1 week on LD12:12, themice were
released into constant darkness (DD) for an additional 3 weeks. Free
running period was measured by linear regression analysis of activity
onsets from data collected during the DD portion of the assay using
ClockLab software (Siepka and Takahashi, 2005b).
Genetic Mapping
Ovtm/Ovtmmale mice were mated to C3H/HeJ female mice to create
(Ovtm/+ 3 C3H/HeJ) F1 mice. The F1 females were backcrossed to
produce 156 ([Ovtm/+ 3 C3H/HeJ] 3 Ovtm/Ovtm) N2 mice for map-
ping. Alternately, Ovtm/Ovtm female mice were mated to C57BL/6J
male mice to create (Ovtm/+ 3 C57BL/6J) F1 mice. These F1 siblings
were intercrossed to produce 1480 (Ovtm 3 C57BL/6J) F2 mice for
mutation mapping. Wheel-running behavior of all mapping mice was
collected and analyzed as described above. Only presumptive Ovtm
homozygous mice (321 genotyped for a total of 642 meioses) were
used for genetic mapping as described in the Supplemental Data.
Sequencing of Candidate Genes
Sequencing was performed either in our laboratory or at the Harvard
Partners Genome Center, Cambridge MA. Genomic DNA was ex-
tracted from tail tips from two wild-type BTBR/J mice and two Ovtm/
Ovtmmice. All annotated exons fromMGSC36within the 4MB interval
between D14Mit265 and D14Mit197, which contains Ovtm, were am-
plified by PCR using genomic DNA templates. Most exons were small
enough to be amplified and sequenced in a single amplicon (600 bp).
Some larger exons however, were sequenced by multiple overlapping
600 bp amplicons. The following genes and the number of exons and
amplicons sequenced were as follows: Tcb1d4 (19 exons, 20 ampli-
cons), Commd6 (4 exons, 3 amplicons), Uch13 (9 exons, 8 amplicons),
Q8C3P1 (1 exon, 2 amplicons), Lmo7 (27 exons, 31 amplicons), Irg1
(5 exons, 8 amplicons), Cln5 (4 exons, 5 amplicons), Fbxl3 (5 exons, 7
amplicons), Phr1 (86 exons, 88 amplicons), AK190093 (3 exons, 0 am-
plicons—due to the highly repetitive nature of the sequence), Scel (31
exons, 30 amplicons), Slain1 (7 exons, 9 amplicons), Ednrb (8 exons, 8
amplicons), D130079A08Rik (2 exons, 3 amplicons), Pou4f1 (3 exons,
4 amplicons), 2610206B13Rik (6 exons, 9 amplicons), 1700009P03Rik
(22 exons, 21 amplicons), andNdfip2 (8 exons, 7 amplicons). A table of
primers sequences used in this project is available on request. Note
that all primers also contained M13 tags (M13 Forward 50-TGTAAAAC
GACGGCCAGT-30 and M13 reverse 50-AACAGCTATGACCATG-30) at
their 50 ends. M13 universal primers were used for all sequencing reac-
tions. Sequencing data were analyzed using Sequencher 4.5 software
(Gene Codes Corporation, Ann Arbor, MI).
Overtime Genotyping
Micewere genotyped for theOvtmmutation using real-time PCR to de-
tect single nucleotide polymorphisms (SNPs). PCR reactions were car-
ried out in 6 ml volumes using 10–25 ng template genomic DNAwith 13
MasterMix for SYBRGreen (Part #4309155, AppliedBiosystems Inc.,Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc. 1021
Foster City, CA) 5 pmoles forward (wild-type forward primer = 50-GTT
GCAAAAATTTGTCAGCaAt-30 or Ovtm forward primer = 50-GTTGCAA
AAATTTGTCAGCaAc-30) and 5 pmoles reverse primer (50-CCCCACAC
ATCTTCACAAACT-30) in MicroAmp 96- or 384-well Optical Reaction
Plates (Applied Biosystems, Inc.). Thermocycling reaction conditions
were as follows: 40 cycles of 95C for 15 s and 60C for 30 s. Data
were collected and analyzed with either an ABI Prism 7700 Sequence
Detector or an ABI 7900HT Fast Real-Time PCR System (Applied
Biosystems, Inc.).
Gene Trap Mouse Production
Mouse embryonic stem cell gene trap line S13-12G1 was obtained
from the Soriano Lab Gene Trap Resource at the Fred Hutchinson
Cancer Research Center, Seattle, WA (http://www.fhcrc.org/science/
labs/soriano/trap.html). The cell line contains a ROSAFARY gene
trap vector (Chen et al., 2004) that disrupts expression of Fbxl3 to cre-
ate a null allele of Fbxl3. The maintenance of ES cells, production of
chimeric mice, and genotyping of the Fbxl3 gene trap are described
in the Supplemental Data.
Immunoblotting and Immunoprecipitation
Immunoblotting was performed as described previously (Yoo et al.,
2004). Antibodies against PER1, PER2, CRY1, CRY2, CLOCK, and
BMAL1weremade as described previously (Lee et al., 2001). Immuno-
precipitation was performed 32 hr after transfection including an 8 hr
treatment of 20 mM MG132 (EMD Biosciences). Harvested cells were
homogenized in EB (20 mM HEPES at pH 7.5, 100 mM NaCl, 0.05%
TritonX-100, 1 mM EDTA, 20 mM NaF, 1 mM Na3OV4, Complete
mini, Roche) and centrifuged at maximum speed for 10 min at 4C.
The supernatants were transferred to fresh tubes and incubated with
2 mg of anti-FLAG or anti-V5 antibodies for 2 hr at 4C. Ten microliters
of 50% protein-A slurry (GE) was added, and the incubation continued
for an additional 1.5 hr. Supernatants were discarded after centrifuga-
tion at 3000 rpm at 4C for 1 min, and protein-A beads were washed
three times with 1 ml EB. Pellets were resuspended in 20 ml of 2 X
SDS sample buffer and boiled for 3 min. Protein samples were sepa-
rated by 10% or 6% SDS-polyacrylamide gel and then transferred
to a nitrocellulose membrane (NEN). Five percent nonfat dry milk in
Tris-buffered saline containing 0.05% Tween20 was used for block-
ing buffer. Anti-HA (Roche), anti-FLAG (Sigma), and anti-V5 (Invitro-
gen) were used to detect CRY1, FBXL3 (or OVTM), and bTRCP1,
respectively.
RNA Isolation and Real-Time PCR
Total RNA was isolated from frozen tissues with Trizol reagent (Invitro-
gen), then treated with DNase (Ambion). A total of 0.5 mg DNase-
treated total RNAwas reverse transcribed using Taqman reverse-tran-
scription reagent (Roche). The cDNA equivalent to 10 ng of total RNA
was PCR-amplified in either an ABI Prism 7700 Sequence Detector or
an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems,
Inc.). RNA expression was quantified by using SYBR green real-time
PCR analysis. Analysis was performed as described previously (Wils-
bacher et al., 2002). Primer sequences are described in the Supple-
mental Data.
Cell Culture and Transfection
Primary fibroblasts were isolated from the ear tissue of wild-type and
Ovtmmutantmice. Briefly, minced ear tissue was incubated with colla-
genase III (1mg/ml) and trypsin (0.05%). After 10min incubationat 37C
minced tissue was allowed to adhere onto a 100 mm culture dish. Ap-
proximately 10 days after culture in DMEM (Mediatech) supplemented
with 10% fetal bovine serum, ear fragments were removed, and out-
growing fibroblasts were replated into T75 flasks by trypsinization.
NIH 3T3 and 293A (ATCC) cells were cultured in DMEM (Mediatech)
supplemented with 10% fetal bovine serum. For immunoprecipita-
tions, 1 3 106 cells were plated into the 100 mm dishes 1 day before
transfection, Effectene reagent (Qiagen) was used to transfect DNA1022 Cell 129, 1011–1023, June 1, 2007 ª2007 Elsevier Inc.according to the manufacturer’s protocol. For the luminescence as-
say, 293A cells were plated the day before transfection at 23 105 cells
per well in 6-well plates. Cells were transfected with indicated vectors
by using Effectene reagent. Forty-eight hours after transfection, cells
were lysed and luminescence was measured from 20 ml of lysate in
the Luciferase Assay System (Promega) using a luminometer (Auto-
Lumet Plus; Berthold Technologies).
Supplemental Data
Supplemental Data include one figure, Supplemental Experimental
Procedures, and Supplemental References and can be found with
this article online at http://www.cell.com/cgi/content/full/129/5/1011/
DC1/.
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